Natriumklorid-Glucos, Viaflo Baxter (Sodium Chloride, Glucose)

Sodium chloride expands the extracellular fluid compartment and restores osmotic balance, while glucose is taken up by cells to serve as a rapid energy source. Together they re‑establish volume, electrolyte, and metabolic homeostasis during acute fluid loss or metabolic stress.

The prescribed dose of Natriumklorid-Glucos is determined by the treating physician based on the patient’s clinical condition, fluid losses, electrolyte status, and glucose needs. The healthcare professional will calculate the appropriate volume and rate of infusion for each individual case.

Safety data for Natriumklorid-Glucos in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and required import documentation.

Natriumklorid-Glucos combines both sodium chloride and glucose in a single intravenous formulation, offering simultaneous fluid, electrolyte, and energy replacement. Some alternatives provide only electrolytes or only dextrose, requiring separate administrations. The combined product can simplify therapy and reduce infusion time when both components are needed.

The product must be stored at 2‑8 °C, protected from light, and should not be frozen or shaken. Keep the vial in its original packaging until use and inspect for particulate matter or discoloration before administration.

Natriumklorid-Glucos is administered intravenously by slow infusion or bolus, as directed by the prescriber. The infusion rate is adjusted according to the patient’s fluid status, electrolyte levels, and clinical response, with continuous monitoring during administration.

Serious risks include severe hypernatremia, fluid overload leading to pulmonary edema, and rare anaphylactic reactions. Prompt recognition of symptoms such as seizures, respiratory distress, or sudden hypotension is essential, and immediate medical intervention should be initiated.

Patients with known hypersensitivity to sodium chloride, glucose, or any excipients in the formulation should avoid the product. It is also contraindicated in individuals with uncontrolled hypernatremia, severe fluid overload, or certain metabolic disorders unless closely monitored by a physician.